Highlights From the Alzheimer’s Association International Conference
JAMA Medical News
Intro
This chapter explores key findings on the effectiveness of plasma biomarker tests, particularly phosphorylated tau 217 (PTAU), for diagnosing Alzheimer's disease. It emphasizes the potential of these tests to enhance clinical practices in both primary and secondary care settings.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
